Cite

HARVARD Citation

    O'Brien, B. et al. (n.d.). PC3 - 155 Phase II Study of Dianhydrogalactitol in Patients with MGMT-Unmethylated, Bevacizumab-Naïve Recurrent Glioblastoma. Canadian journal of neurological sciences. p. S18. [Online]. 
  
Back to record